These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20860809)
1. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. Widmer LL; Blank PR; Van Herck K; Hatz C; Schlagenhauf P BMC Infect Dis; 2010 Sep; 10():279. PubMed ID: 20860809 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
3. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
4. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Massad E; Behrens BC; Coutinho FA; Behrens RH Malar J; 2011 May; 10():130. PubMed ID: 21586155 [TBL] [Abstract][Full Text] [Related]
5. Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Pistone T; Schwarzinger M; Chauvin P; Ezzedine K; Receveur MC; Djossou F; Siriwardana M; Larouzé B; Malvy D Health Policy; 2008 Dec; 88(2-3):186-99. PubMed ID: 18440663 [TBL] [Abstract][Full Text] [Related]
6. Mefloquine for preventing malaria during travel to endemic areas. Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100 [TBL] [Abstract][Full Text] [Related]
8. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. Schlagenhauf P; Tschopp A; Johnson R; Nothdurft HD; Beck B; Schwartz E; Herold M; Krebs B; Veit O; Allwinn R; Steffen R BMJ; 2003 Nov; 327(7423):1078. PubMed ID: 14604928 [TBL] [Abstract][Full Text] [Related]
9. Should anti-malarial chemoprophylaxis be reimbursed in France? A cost-effectiveness analysis of different reimbursement strategies. Fiorina C; Josselin JM; Trépart-Normand M; Tattevin P; Bajeux E Infect Dis Now; 2022 Sep; 52(6):349-357. PubMed ID: 35760347 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data. Zuckerman JN; Batty AJ; Jones ME Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009 [TBL] [Abstract][Full Text] [Related]
11. Does public subsidy of the cost of malaria chemoprophylaxis reduce imported malaria? A comparative policy analysis. Neave PE; Taylor S; Behrens RH Malar J; 2013 Jul; 12():238. PubMed ID: 23848986 [TBL] [Abstract][Full Text] [Related]
12. Malaria prevention strategies and recommendations, from chemoprophylaxis to stand-by emergency treatment: a 10-year prospective study in a Swiss Travel Clinic. Boubaker R; Hérard Fossati A; Meige P; Mialet C; Ngarambe Buffat C; Rochat J; Souvannaraj-Blanchant M; Uwanyiligira M; Widmer F; Payot S; Rochat L; de Vallière S; D'Acremont V; Genton B J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28931142 [TBL] [Abstract][Full Text] [Related]
15. Malaria knowledge and utilization of chemoprophylaxis in the UK population and in UK passengers departing to malaria-endemic areas. Behrens RH; Alexander N Malar J; 2013 Dec; 12():461. PubMed ID: 24359323 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis. Islam N; Wright S; Lau CL; Doi SAR; Mills DJ; Clark J; Clements ACA; Furuya-Kanamori L J Travel Med; 2021 Jul; 28(5):. PubMed ID: 33834208 [TBL] [Abstract][Full Text] [Related]